Personal Profile
Training and Appointment
Mr Arumainayagam grew up near Southampton and completed his undergraduate training at Nottingham University Medical School. He then undertook house officer posts and senior house officer basic surgical training posts in London and Bristol.
He spent time doing research at University College London Hospital, investigating the role of multi-parametric MRI in diagnosing and excluding prostate cancer. He also ran focal therapy trials (HIFU and photodynamic therapy), before higher urological training as an SpR (specialist registrar) on the North West London (Imperial) training scheme at St Mary’s Hospital, The Royal Marsden Hospital, West Middlesex Hospital, Charing Cross Hospital, Hillingdon Hospital and Northwick Park Hospital.
Mr Arumainayagam completed a year of sub-speciality training in stone surgery at Charing Cross Hospital as a senior specialist registrar and gained extensive experience in treating kidney stones through a variety of surgical techniques. He was Clinical Stone Lead at Ashford and St Peter’s Hospital NHS Trust.
After being appointed as a consultant in April 2015, Mr Arumainayagam has treated a wide range of general urological conditions and can provide novel treatments for benign prostatic enlargement (Urolift, Rezum, Greenlight PVP, TURP surgery and prostate artery embolisation). He is also able to provide prostate diagnostic services for men with raised PSA (multi-parametric MRI and transperineal template mapping biopsy and targeted fusion biopsy). Part of his clinical work is evaluation for haematuria (blood in the urine) and management of bladder cancer.
Current Practice
Mr Arumainayagam is currently the Clinical Lead (Clinical Director) for Urology and the Lead Cancer Clinician for Ashford and St Peter’s Hospitals NHS Trust. He is the Foundation Year 2 Training Programme Director at the Trust and also the principal investigator at Ashford and St Peter’s Hospital for numerous prostate cancer clinical trials (PROFILE, CADMUS study, INDEX study, PRONOUNCE trial, CHRONOS and PROSPECT trials).
He strives to be available and flexible for his patients and provides a patient-centred, individually tailored approach in the care of his patients.
